Lynn D. Kramer
Eisai (United States)(US)Eisai (Japan)(JP)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Epilepsy research and treatment, Health Systems, Economic Evaluations, Quality of Life, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → Lecanemab in Early Alzheimer’s Disease(2022)4,787 cited
- → Core outcome measures for chronic pain clinical trials: IMMPACT recommendations(2004)3,666 cited
- → Core outcome domains for chronic pain clinical trials: IMMPACT recommendations(2003)3,481 cited
- → Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations(2007)3,314 cited
- → A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody(2021)772 cited
- → The β-Secretase BACE1 in Alzheimer’s Disease(2020)632 cited
- →